Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    12542598 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Terlipressin in Cirrhotic Patients With Recidivation Ascites Treated With Paracentesis and Albumin
Condition: Cirrhosis
Interventions: Drug: Terlipressin;   Drug: Placebo
2 Enrolling by invitation Study to Evaluate if the Drug Vasopressin Protects the Kidneys for Patients Undergoing Liver Transplant
Condition: Liver Failure
Interventions: Drug: Vasopressin;   Drug: Normal saline placebo
3 Completed Study of Terlipressin Versus Placebo to Treat Hepatorenal Syndrome Type 1
Condition: Hepatorenal Syndrome
Intervention: Drug: terlipressin

Study has passed its completion date and status has not been verified in more than two years.